chevron_leftBack
As of 20 June 2026, Syncom Formulations (India) Ltd. has a market cap of $137.14M USD, ranking #23421 globally and #1387 in India.
It ranks #2105 in the Healthcare sector, and #759 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$137.14MUSD
12.94B INR
Enterprise Value
$121.8MUSD
11.5B INR
Revenue (TTM)
$53.25MUSD
5.03B INR
EBITDA (TTM)
$7.67MUSD
723.99M INR
Net Income (TTM)
$7.31MUSD
689.58M INR
EBITDA Margin
14%
Profit Margin
14%
PE Ratio
18.8
PS Ratio
2.6
PB Ratio
3.4
EV/EBITDA
15.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Vijay Bankda
open_in_new
Employees
744
Founded
1988
Website
syncomformulations.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.4% | -0.8% | 26% | 9.8% | -18% | -18% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
SYNCOMF
Syncom Formulation (India) Ltd
ISIN: INE312C01025
Shares Out.:
Shares Outstanding:
940.0M1
Shares Float:
462.118M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
13.74 INR | |
|
524470
(SYNCOMF)
Syncom Formulation (India) Ltd
ISIN: INE312C01025
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
13.77 INR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Syncom Formulations (India) Ltd.
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, and the right nutrition products under the Cratus brand. In addition, the company offers its pharmaceutical formulation products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NSE: SUNPHARMA
|
$45.22B
33K%
4.27T INR
|
39.1
|
|
NSE: DIVISLAB
|
$18.38B
13K%
1.73T INR
|
70.0
|
|
NSE: TORNTPHARM
|
$15.17B
11K%
1.43T INR
|
63.0
|
|
NSE: DRREDDY
|
$11.73B
8K%
1.11T INR
|
19.6
|
|
NSE: MANKIND
|
$9.87B
7K%
931.67B INR
|
52.2
|
|
NSE: ZYDUSLIFE
|
$9.71B
7K%
916.53B INR
|
18.6
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
555K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
399K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
263K%
|
97.4
|
|
SIX: RO
|
$318.3B
232K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$284.64B
207K%
215.59B GBP
|
27.6
|
|
NYSE: MRK
|
$274.03B
200K%
|
15.1
|
chevron_leftBack